Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Perrigo Company, a manufacturer of over-the-counter and generic prescription pharmaceuticals, has received final approval from the FDA to market sulfacetamide sodium topical suspension, 10%.
Subscribe to our email newsletter
The sulfacetamide sodium topical suspension, 10% (lotion) has been determined to be therapeutically equivalent to Sanofi-Aventis’s Klaron lotion, 10%, which is indicated for the topical treatment of acne.
Joseph Papa, chairman and CEO of Perrigo, said: “This approval is another example of our commitment to invest in and bring new products to market. It further demonstrates our strategy to deliver quality affordable healthcare both behind and over the counter.”